B. Watkins

发表

Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8+ T cells drive gastrointestinal acute graft-versus-host disease

E. L. Potter, A. Shalek, S. Furlan, 2021, Science Translational Medicine.

A phase I study of sirolimus in combination with metronomic therapy (CHOAnome) in children with recurrent or refractory solid and brain tumors

T. MacDonald, C. Wetmore, M. Tighiouart, 2019, Pediatric blood & cancer.

CD28 blockade controls T cell activation to prevent graft-versus-host disease in primates

S. Furlan, Lucrezia Colonna, A. Panoskaltsis-Mortari, 2018, The Journal of clinical investigation.

Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation

M. Norkin, S. Choi, M. Qayed, 2021, Blood advances.

Combined OX40L and mTOR blockade controls effector T cell activation while preserving Treg reconstitution after transplant

S. Furlan, Jeffrey S. Miller, B. Blazar, 2017, Science Translational Medicine.

Spatiotemporal single-cell profiling of gastrointestinal GVHD reveals invasive and resident memory T cell states

E. L. Potter, A. Shalek, S. Furlan, 2020, bioRxiv.

Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells.

S. Furlan, Jeffrey S. Miller, B. Blazar, 2016, Blood.

Preclinical Testing of Antihuman CD28 Fab′ Antibody in a Novel Nonhuman Primate Small Animal Rodent Model of Xenogenic Graft-Versus-Host Disease

J. Tolar, B. Blazar, V. Tkachev, 2016, Transplantation.

The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques

S. Furlan, A. Kirk, B. Blazar, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

CD8-predominant T-cell CNS infiltration accompanies GVHD in primates and is improved with immunoprophylaxis.

S. Furlan, S. Westmoreland, C. Courtney, 2014, Blood.

Controversies and expectations for the prevention of GVHD: A biological and clinical perspective

K. Williams, B. Watkins, 2022, Frontiers in Immunology.

Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD

M. Norkin, S. Furlan, M. Pasquini, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transcriptome analysis of GVHD reveals aurora kinase A as a targetable pathway for disease prevention

C. Ziegler, S. Furlan, D. Promislow, 2015, Science Translational Medicine.

CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire.

Bruce R. Blazar, Allan D. Kirk, John Horan, 2015, Blood.

Comparison of automated red cell exchange transfusion and simple transfusion for the treatment of children with sickle cell disease acute chest syndrome

Xinyu Tang, B. Watkins, S. Saccente, 2013, Pediatric blood & cancer.

Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.

M. Qayed, A. Haight, K. Williams, 2022, Blood advances.

Preclinical testing of anti-human CD28 Fab' antibody in a novel nonhuman primate (NHP) small animal rodent model of xenogenic graft-versus-host disease (GVHD).

J. Tolar, B. Blazar, V. Tkachev, 2016, Transplantation.

Persistence of Virus Reservoirs in ART-Treated SHIV-Infected Rhesus Macaques after Autologous Hematopoietic Stem Cell Transplant

G. Silvestri, L. Kean, A. Chahroudi, 2014, PLoS pathogens.

T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival

M. Norkin, M. Pasquini, S. Choi, 2017 .

Blinatumomab induces complete response in refractory PTLD after hematopoietic cell transplantation

K. Leung, E. Horwitz, M. Qayed, 2022, Blood advances.

Early blood stream infection following allogeneic hematopoietic stem cell transplantation is a risk factor for acute grade III–IV GVHD in children and adolescents

M. Qayed, K. Chiang, J. Hilinski, 2018, Pediatric blood & cancer.

A retrospective review on the histopathological pattern of childhood malignant solid tumors in Ethiopia.

L. Muhe, S. Cunningham, Shivani A. Patel, 2023, Pediatric blood & cancer.

BCMA CAR-T induces complete and durable remission in refractory plasmablastic lymphoma

M. Dhodapkar, K. Leung, J. Kaufman, 2023, Journal for ImmunoTherapy of Cancer.

T Cell Costimulation Blockade with CTLA4-Ig (Abatacept) for Acute Gvhd Prevention in HLA Matched and Mismatched Unrelated Donor Transplantation: Results of the First Phase 2 Trial

M. Norkin, M. Pasquini, M. Tighiouart, 2019, Biology of Blood and Marrow Transplantation.

Diffuse alveolar hemorrhage after hematopoietic cell transplantation- response to treatments and risk factors for mortality

Adrianna L Westbrook, P. Kamat, M. Qayed, 2023, Frontiers in oncology.

Abatacept for the Prevention of Gvhd in Pediatric and Adult Patients Receiving 7/8 HLA-Mismatched Unrelated Transplant for Hematologic Malignancies: A Real-World Analysis

Adrianna L Westbrook, M. Qayed, L. Kean, 2022, Blood.

Early Breakthrough T Cell Proliferation Despite CNI/MTX Prophylaxis Is a Harbinger of Acute Gvhd (AGVHD) and Is Controlled By Abatacept: Mechanism of Success of the ABA2 Agvhd Prevention Trial

L. Cagnin, A. Eran, B. Blazar, 2022, Blood.

Setting up a pediatric oncology program in Cambodia: successes and challenges

L. Kean, S. Howard, I. Qaddoumi, 2017 .

Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure

K. Leung, M. Qayed, L. Kean, 2023, Blood advances.

Higher Abatacept Exposure Decreases Acute GVHD Risk Without Increasing Adverse Events.

D. Neuberg, S. Choi, B. Blazar, 2023, Blood.

Abatacept for the prevention of GVHD in patients receiving mismatched unrelated transplants: a real-world analysis

Adrianna L Westbrook, M. Qayed, L. Kean, 2023, Blood advances.

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies

Adrianna L Westbrook, M. Qayed, L. Kean, 2023, Bone Marrow Transplantation.

Abatacept for the prevention of graft versus host disease in pediatric patients receiving 7/8 HLA-mismatched unrelated transplant for hematologic malignancies: a real-world analysis

D. Neuberg, M. Qayed, L. Kean, 2023, Bone Marrow Transplantation.